Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis

Antipsychotic-induced hyperprolactinemia (AP-induced HPRL) occurs overall in up to 70% of patients with schizophrenia, which is associated with hypogonadism and sexual dysfunction. We summarized the latest evidence for the benefits of prolactin-lowering drugs. We performed network meta-analyses to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhe, Sun, Yaoyao, Zhang, Yuyanan, Chen, Yu, Guo, Liangkun, Liao, Yundan, Kang, Zhewei, Feng, Xiaoyang, Yue, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256633/
https://www.ncbi.nlm.nih.gov/pubmed/35790713
http://dx.doi.org/10.1038/s41398-022-02027-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256633/
https://www.ncbi.nlm.nih.gov/pubmed/35790713
http://dx.doi.org/10.1038/s41398-022-02027-4

Ejemplares similares